Technologies - Momentum Biotechnologies

We offer a powerful portfolio of proteomic and chemoproteomic technologies to support drug discovery and research efforts.

Developed by OmicScouts, A Momentum Biotechnologies Company, this flexible and scalable assay suite enables researchers to comprehensively characterize protein properties across a range of contexts. Most technologies can be applied to multiple stages of the drug discovery and development pipeline, and all can be further customized to address specific experimental needs, such as increased throughput, challenging sample types, etc.

CHIPP
Sensitive, label-free, and scalable drug:target profiling
CysScout™
Profiling of reactive cysteines
DecryptM
Concentration-resolved PTM profiling
KinomeScout™
Target profiling for kinases and other ATP-binding proteins
NucleoBeads™
Identifying and characterizing functional inhibitors of DNA-binding proteins and transcription factors
PhotoTargetScout™
Photo-affinity labeling and identification of compound-binding proteins
PlasmaScout™
Clinical proteomics of plasma and serum proteins
Protein Turnover Atlas™
On-demand access to protein turnover data
Proteome Atlas™
Protein expression data across cell lines & tissues
ProteomeScout™
Deep and rapid proteome profiling
QuantScout™
Targeted quantification of relevant proteoforms with maximum accuracy
SignalingScout™
Proteome-wide phosphorylation profiling
SPICE
Label-free target profiling in cells with biophysical proteomics
SurfaceScout™
Profiling of cell surface proteomes
TargetScout™
Versatile, robust, and scalable platform for compound pulldowns
TurnoverScout™
Global profiling of protein synthesis and degradation
UbiScout™
Profiling of ubiquitination sites